JOURNEY MEDICAL CORP (DERM:NASDAQ)
$5.17 -0.02 (-0.3854%)
Analysed JOURNEY MEDICAL CORP (DERM:NASDAQ) News Sources
Why The Journey Medical (DERM) Narrative Is Shifting With New Targets And Going Concern Risks
30-03-2026
yahoo.com
Journey Medical (DERM) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
26-03-2026
yahoo.com
Journey Medical Corporation Q4 2025 Earnings Call Summary
26-03-2026
moby.co
Journey Medical Corp (DERM) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...
26-03-2026
yahoo.com
Journey Medical Q4 Earnings Call Highlights
26-03-2026
marketbeat.com
Journey Medical Corporation Reports Full-Year 2025 Financial Results and Recent Corporate Highlights
25-03-2026
yahoo.com
Journey Medical Corporation to Announce Year End 2025 Financial Results on March 25, 2026
18-03-2026
yahoo.com
Journey Medical (DERM) Publishes Positive Emrosi Phase 1 Microbiome Data
08-01-2026
yahoo.com
Public companies account for 34% of Journey Medical Corporation's (NASDAQ:DERM) ownership, while institutions account for 33%
22-12-2025
yahoo.com
Journey Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi™ (DFD-29) on Microbial Flora of Healthy Adults in the Journal of Drugs in Dermatology
10-12-2025
yahoo.com
What is the current price of JOURNEY MEDICAL CORP (DERM:NASDAQ)?
The current price of JOURNEY MEDICAL CORP (DERM:NASDAQ) is $5.17.
JOURNEY MEDICAL CORP (DERM:NASDAQ) absolute price change since previous trading day?
The absolute price change of JOURNEY MEDICAL CORP (DERM:NASDAQ) since the previous trading day is $-0.02.
JOURNEY MEDICAL CORP (DERM:NASDAQ) percentage price change since previous trading day?
The percentage price change of JOURNEY MEDICAL CORP (DERM:NASDAQ) since the previous trading day is -0.3854%.
What is the most recent average sentiment score for JOURNEY MEDICAL CORP (DERM:NASDAQ)?
The most recent average sentiment score for JOURNEY MEDICAL CORP (DERM:NASDAQ) is 78 out of 100.
What is the most recent average sentiment for JOURNEY MEDICAL CORP (DERM:NASDAQ)?
The most recent sentiment for JOURNEY MEDICAL CORP (DERM:NASDAQ) is .
SEC-8K** Filing Available For JOURNEY MEDICAL CORP (DERM:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.